Estrogen and progesterone receptors in breast carcinoma: Quantitation is therapeutically important

[1] BAEHNER FL, 2007, ASCO BREAST CANC S

[2] Bimodal frequency distribution of estrogen receptor immunohistochemical staining results in breast cancer [J]. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2005, 123 (01) : 16 - 20

[3] Measurement of gene expression in archival paraffin-embedded tissues - Development and performance of a 92-gene reverse transcriptase-polymerase chain reaction assay [J]. AMERICAN JOURNAL OF PATHOLOGY, 2004, 164 (01) : 35 - 42

[4] DEGENSHEIN GA, 1980, CANCER-AM CANCER SOC, V46, P2789, DOI 10.1002/1097-0142(19801215)46:12+<2789::AID-CNCR2820461409>3.0.CO

[5] 2-K

[6] BIOLOGIC SIGNIFICANCE OF QUANTITATIVE ESTROGEN-RECEPTOR IMMUNOHISTOCHEMICAL ASSAY BY IMAGE-ANALYSIS IN BREAST-CANCER [J]. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1994, 102 (02) : 158 - 162

[7] ESTEBAN JM, 1994, AM J CLIN PATHOL, V102, pS9

[8] FLANAGAN MB, 2008, MOD PATHOL IN PRESS

[9] Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer [J]. JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (05) : 1474 - 1481

[10] Advances in adjuvant endocrine therapy for postmenopausal women [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (05) : 798 - 805

[1] BAEHNER FL, 2007, ASCO BREAST CANC S

[2] Bimodal frequency distribution of estrogen receptor immunohistochemical staining results in breast cancer [J]. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2005, 123 (01) : 16 - 20

[3] Measurement of gene expression in archival paraffin-embedded tissues - Development and performance of a 92-gene reverse transcriptase-polymerase chain reaction assay [J]. AMERICAN JOURNAL OF PATHOLOGY, 2004, 164 (01) : 35 - 42

[4] DEGENSHEIN GA, 1980, CANCER-AM CANCER SOC, V46, P2789, DOI 10.1002/1097-0142(19801215)46:12+<2789::AID-CNCR2820461409>3.0.CO

[5] 2-K

[6] BIOLOGIC SIGNIFICANCE OF QUANTITATIVE ESTROGEN-RECEPTOR IMMUNOHISTOCHEMICAL ASSAY BY IMAGE-ANALYSIS IN BREAST-CANCER [J]. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1994, 102 (02) : 158 - 162

[7] ESTEBAN JM, 1994, AM J CLIN PATHOL, V102, pS9

[8] FLANAGAN MB, 2008, MOD PATHOL IN PRESS

[9] Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer [J]. JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (05) : 1474 - 1481

[10] Advances in adjuvant endocrine therapy for postmenopausal women [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (05) : 798 - 805